Bruker Q3 Revenues Down 6 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Bruker reported today that its revenues in the third quarter were down 6 percent year over year, falling to $396.1 million from $419.8 million in Q3 2014 but beating analysts' consensus estimate of $373.7 million.

Excluding a 3 percent negative effect from divestitures and an 11 percent negative effect from currency exchange rates, the company posted Q3 organic growth of 8 percent. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.